Using modern methods and technologies, Personal Genome Diagnostics (PGDx) develops a patient-specific study of the cancer genome. It enables in-house tumor profiling with our portfolio of RUO and IVD tissue, liquid biopsy-based genomic products, and sophisticated bioinformatics solutions, allowing for a deeper knowledge of tumor biology and biomarker-informed treatment strategies. By accessing actionable information from the genome, PGDx aids in the battle against cancer. The company is working on a portfolio of regulated tissue-based and liquid biopsy genomic solutions for laboratories all around the world.
PERSONAL GENOME DIAGNOSTICS Pricing
to get more information.